1992
DOI: 10.1016/s0196-0644(05)80895-9
|View full text |Cite
|
Sign up to set email alerts
|

Aminophylline hypersensitivity apparently due to ethylenediamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2000
2000
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 14 publications
0
10
0
Order By: Relevance
“…The asthma drug aminophylline is a complex of ethylenediamine and theophylline. Systemic reactions have been reported after use of this preparation, and have been explained as hypersensitivity reactions to ethylenediamine (14)(15)(16). Ethylenediamine has also been used as a stabilizer in antibiotic and corticosteroid creams, and has been a common cause of allergic reactions (17).…”
Section: Discussionmentioning
confidence: 99%
“…The asthma drug aminophylline is a complex of ethylenediamine and theophylline. Systemic reactions have been reported after use of this preparation, and have been explained as hypersensitivity reactions to ethylenediamine (14)(15)(16). Ethylenediamine has also been used as a stabilizer in antibiotic and corticosteroid creams, and has been a common cause of allergic reactions (17).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, an entire family of antihistamines is derived from EDA (hydroxyzine, pyrilamine and tripelenamine), and some cross‐reactions have been reported systematically and topically 4,18 . Although rare, the allergic reactions to these EDA derivatives may result in significant morbidity 17 …”
Section: Introductionmentioning
confidence: 99%
“…Unlike theophylline with its low solubility, aminophylline has mostly been used as an injectable treatment and there have been various reports on its efficacy 1–5 . However, aminophylline is a mixture of ethylenediamine sodium and theophylline, and allergic reactions to the ethylenediamine component, including urticaria and dyspnoea, have been reported 7–10 . Intravenously administered theophylline (IAT) was developed in 2000.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3][4][5] However, aminophylline is a mixture of ethylenediamine sodium and theophylline, and allergic reactions to the ethylenediamine component, including urticaria and dyspnoea, have been reported. [7][8][9][10] Intravenously administered theophylline (IAT) was developed in 2000. Unlike aminophylline, solubilized theophylline is not combined with ethylenediamine and it is, therefore, expected to have fewer side-effects.…”
Section: Introductionmentioning
confidence: 99%